Clinical trial reportAnnals of oncology : official journal of the European Society for Medical OncologyPublished
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of oncology : official journal of the European Society for Medical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Neoplasm Recurrence, Local; Estradiol; Inhibins; Follicle Stimulating Hormone; Receptors, Estrogen; Receptors, Progesterone; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Chemotherapy, Adjuvant; Adult
- PubMed ID
- 42613139
- PubMed Central ID
- PMC13488494
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked